NRX Pharmaceuticals Inc (NRXP)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.10B
EV to revenue ratio (TTM)
22.74
EV to ebitda
-0.15
Financial Performance
Revenue (TTM)
$0.00B
Gross profit (TTM)
$0.00B
EBITDA
-$0.02B
Profitability
Operating margin (TTM)
-590.00%
Profit margin
<0.01%
Return on assets (TTM)
-64.00%
Return on equity (TTM)
-683.00%
Per Share Metrics
Revenue per share (TTM)
$0.11
EPS
-$0.58
Diluted EPS (TTM)
-$0.58
Book value
$0
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
34.25
PEG ratio
n/a
Price to sales ratio (TTM)
30.36
Price to book ratio (TTM)
2.90
Growth
Quarterly earnings growth (YoY)
<0.01%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
0
Buy
4
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
2.06